And this is the big question:
Was this done?
“So, Ii-Key is going to be protected for a much longer time; I can address the clinical trial questions, we're filing the IND by the end of June--the first day of July is the latest that we can possibly do it as far as I’m concerned on my internal timeline, anyway--and we expect to be able to initiate our Phase 1 trial with 159 patients targeted based upon the FDA's approval of the protocol; they have it, we submitted that protocol to them.
And it's a very complex and complicated protocol that PPD helped us put together,..”
Read More: https://investorshangout.com/post/view?id=620...z72yxuRNYn
Was this done?
“So, Ii-Key is going to be protected for a much longer time; I can address the clinical trial questions, we're filing the IND by the end of June--the first day of July is the latest that we can possibly do it as far as I’m concerned on my internal timeline, anyway--and we expect to be able to initiate our Phase 1 trial with 159 patients targeted based upon the FDA's approval of the protocol; they have it, we submitted that protocol to them.
And it's a very complex and complicated protocol that PPD helped us put together,..”
Read More: https://investorshangout.com/post/view?id=620...z72yxuRNYn
